Literature DB >> 2440986

Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies.

D M Morens, L K Larsen, S B Halstead.   

Abstract

Dengue 2 (DEN-2) strains isolated from children during the 1980 metropolitan Bangkok epidemic were shown to possess antigenic homogeneity when studied for determinants mediating antibody-dependent infection enhancement using DEN-2 monoclonal antibodies. All isolates possessed multiple enhancing determinants, but those associated with mild and severe dengue syndromes could not be distinguished. Either the basis of disease severity in dengue is more complex than the mere presence or absence of virus epitopes involved in enhanced infection or enhancing epitopes have differences not detected in this system with monoclonal antibodies raised to the same serotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440986     DOI: 10.1002/jmv.1890220207

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.

Authors:  N Ferguson; R Anderson; S Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Variation of the nucleotide and encoded amino acid sequences of the envelope gene from eight dengue-2 viruses.

Authors:  J Blok; S Samuel; A J Gibbs; U T Vitarana
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.

Authors:  Manisha Saini; Sudhanshu Vrati
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response.

Authors:  Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton
Journal:  Nat Immunol       Date:  2017-09-25       Impact factor: 25.606

5.  Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.

Authors:  Meng Ling Moi; Chang-Kweng Lim; Kaw Bing Chua; Tomohiko Takasaki; Ichiro Kurane
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

6.  Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.

Authors:  Minh Huong Phu Ly; Meng Ling Moi; Thi Bich Hau Vu; Mya Myat Ngwe Tun; Todd Saunders; Cam Nhat Nguyen; Anh Kieu Thi Nguyen; Hung Manh Nguyen; Than Huu Dao; Do Quyen Pham; Thi Thu Thuy Nguyen; Thi Quynh Mai Le; Futoshi Hasebe; Kouichi Morita
Journal:  BMC Infect Dis       Date:  2018-01-10       Impact factor: 3.090

7.  First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies.

Authors:  Jowin Kai Wei Ng; Summer Lixin Zhang; Hwee Cheng Tan; Benedict Yan; Julia Maria Martinez; Wei Yu Tan; Jian Hang Lam; Grace Kai Xin Tan; Eng Eong Ooi; Sylvie Alonso
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.